Molecular determinants of Ebola virus virulence in mice.
about
Animal models for Ebola and Marburg virus infectionsThe Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivoCurrent ebola vaccinesFiloviral immune evasion mechanismsIntracellular events and cell fate in filovirus infectionMutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcomeEbola haemorrhagic feverAdaptation of Borna disease virus to new host species attributed to altered regulation of viral polymerase activityAdapted Lethality: What We Can Learn from Guinea Pig-Adapted Ebola Virus Infection ModelEbolavirus Evolution: Past and PresentFiloviruses: One of These Things is (not) Like the OtherAnimal models of respiratory syncytial virus infection and diseaseMouse models for filovirus infectionsMarburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola VirusRabies Virus Nucleoprotein Functions To Evade Activation of the RIG-I-Mediated Antiviral ResponseMutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea PigsThe Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal FoldCrystal Structure of Marburg Virus VP24Flavonoids as multi-target inhibitors for proteins associated with Ebola virus: in-silico discovery using virtual screening and molecular docking studies.Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies.A seroepidemiologic study of Reston ebolavirus in swine in the PhilippinesMolecular basis for a lack of correlation between viral fitness and cell killing capacityDevelopment and characterization of a mouse model for Marburg hemorrhagic feverEfficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome VirusVirus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNAThe Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import.How Ebola virus counters the interferon system.Serological evidence of Ebola virus infection in Indonesian orangutans.Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.Filovirus replication and transcription.Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.Camouflage and misdirection: the full-on assault of ebola virus diseaseEbolavirus Database: Gene and Protein Information Resource for EbolavirusesAnalysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.An update on the use of antibodies against the filoviruses.Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityTackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.
P2860
Q21131118-7A57ABEC-0598-44A0-A86C-B629EDFB9B14Q21131393-C66DD579-BA93-4387-B785-4754EBB26A9CQ21534720-D37A0AAC-614C-4B2A-9DCC-76F043A58974Q22305519-492279AB-FEA6-4C9C-BD3D-823CE19F3D4EQ22305521-76E3665A-7EFF-40E6-8A12-99E74177BBA5Q24310145-869005A4-3DB5-41A2-BF16-F5F6F27F7F41Q24629338-AF3B4DF8-7300-4624-BF98-4BD37FE5CC65Q24676206-3D0C763B-4F96-4330-81D7-879B27E4E9F7Q26753858-E0AA97F0-FE92-4916-94A6-7326CF5F9DC6Q26777336-D0DCEB50-4178-4270-B0A4-5451C45F1DA6Q26783063-F9A18FD8-0DA5-4582-965B-6F5E9FD3D2BCQ26801458-F7351C16-DF28-4BB9-B2B8-AD91A70C41E4Q27011569-5ABA9AF7-8D54-44FC-87E5-64D00945C320Q27490714-86B4736C-292A-4862-991B-B348BACF7A6DQ27491327-4FA9F2EA-DC7F-4503-9931-C793B48D8D4AQ27658947-43FCF0C5-CDA1-426A-A8C1-0128E0394D9AQ27677595-64BDD06D-A02F-4385-9D69-C76733A75DA1Q27681924-1FF91FEB-9B99-4A1C-92D8-9DE17A40999DQ30371564-0AEFCE14-8CDB-4257-AEFA-9BF79822D1ACQ30378093-B40CAF2C-F404-4506-948C-5AEDF2C23516Q31065625-AAF733CE-F6E8-4E6D-9AA8-D8E2369CCADFQ33282045-6B3BA8F7-E173-4D86-835D-B4E6352AEB86Q33384111-5D4A8B81-0E67-4531-85FE-CA3F5DF73068Q33433096-95BD1F21-6A51-4698-BDF4-53031B949215Q33568288-59AFBA77-01BC-4A26-99B7-5952889B8364Q34222991-2DCBE0E8-5F0A-48D5-9491-A048C1867D40Q34298213-DDD53F57-5A5F-4BCE-88BD-16DA65211BB8Q34345098-5A6CC102-4A9B-44E0-B500-2EA808C687CDQ34371001-AA016951-EBBE-4133-BB36-9C2D54815C97Q34375243-4BCE473E-8F35-4932-8F14-FE9A66371675Q34445647-83909BED-5E72-4535-AD83-1BCD2FE9CBFDQ34449079-C34C7E0B-9CF2-49FA-97C0-647FA7CEF8C8Q34527039-AB6CD17D-CF40-4703-BD73-D40629F2DD10Q34593723-1B354C57-800B-4295-8D5E-36316824BDB3Q34632946-A861C2D4-082A-4865-8A02-50EA2FBCD442Q34657170-49E3E44C-E3AA-4301-AA90-267F5C50D1B1Q34898131-03EEC452-EACE-45FA-BBBD-7033FE9D1F78Q34971349-A8FD3072-FADA-4A73-A850-98E8784A41A6Q35076563-EC3F5172-607C-4B9C-90BB-B032CE3D9224Q35076858-97FAC51C-9107-44DA-BC1E-15005E8E794A
P2860
Molecular determinants of Ebola virus virulence in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular determinants of Ebola virus virulence in mice.
@ast
Molecular determinants of Ebola virus virulence in mice.
@en
type
label
Molecular determinants of Ebola virus virulence in mice.
@ast
Molecular determinants of Ebola virus virulence in mice.
@en
prefLabel
Molecular determinants of Ebola virus virulence in mice.
@ast
Molecular determinants of Ebola virus virulence in mice.
@en
P2093
P2860
P50
P1433
P1476
Molecular determinants of Ebola virus virulence in mice.
@en
P2093
Ayato Takada
Gabriele Neumann
Steven Jones
Steven Theriault
P2860
P356
10.1371/JOURNAL.PPAT.0020073
P577
2006-07-01T00:00:00Z